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Abstract 
Over the last decade, there has been increased interest in the role of the gut microbiome in health 
including brain health. This is by no means a new theory; Elie Metchnikoff proposed over a century 
ago that targeting the gut by consuming lactic acid bacteria such as those in yogurt, could improve 
or delay the onset of cognitive decline associated with ageing. However, there is limited 
information characterising the relationship between the behavioural and physiological sequelae of 
aging and alterations in the gut microbiome. To this end, we assessed the behavioural, 
physiological and caecal microbiota profile of aged male mice. Older mice (20-21 months old) 
exhibited deficits in spatial memory and increases in anxiety-like behaviours compared to younger 
mice (2-3 months old). They also exhibited increased gut permeability, which was directly 
correlated with elevations in peripheral pro-inflammatory cytokines. Furthermore, stress 
exacerbated the gut permeability of aged mice. Examination of the caecal microbiota revealed 
significant increases in phylum TM7, family Porphyromonadaceae and genus Odoribacter of aged 
mice.  This represents a shift of aged microbiota towards a profile previously associated with 
inflammatory disease, particularly gastrointestinal and liver disorders. Furthermore, 
Porphyromonadaceae, which has also been associated with cognitive decline and affective 
disorders, was directly correlated with anxiety-like behaviour in aged mice. These changes 
suggest that changes in the gut microbiota and associated increases in gut permeability and 
peripheral inflammation may be important mediators of the impairments in behavioural, affective 
and cognitive functions seen in ageing.     
  
1. Introduction 
 
Over 100 years ago, Nobel Prize winner Elie Metchnikoff hypothesised that beneficial bacteria 
contained in fermented foods could influence health and delay cognitive decline by manipulating 
the intestinal environment (Mackowiak 2013, Cryan and Dinan 2015). Although popular at the 
time, the theory was largely ignored by the medical community until a recent resurgence in interest 
over the past 20 years (Mackowiak 2013). The gut microbiome is now recognised to play a critical 
role in health and disease, and this is especially true at the extremes of life (Brussow 2013, Borre 
et al. 2014, Candela et al. 2014, Diaz Heijtz 2016, Dinan and Cryan 2016). Indeed, changes in 
microbial composition have been shown to have a distinct impact on health outcomes in infants 
and in the elderly and also is thought to play a key role in modulating gut-brain axis function, 
influencing brain and behaviour (Jeffery and O'Toole 2013, Borre et al. 2014). However, there is 
limited information on how ageing regulates this axis.  With advances in healthcare, longevity has 
markedly increased; currently it is estimated that within 50 years, approximately 20% of the world 
population will be classified as elderly (Ellison et al. 2015). Ageing is associated with a number of 
behavioural and physiological changes, including physical decline, altered mood and cognitive 
impairments (Ellison et al. 2015, Eshkoor et al. 2015, Joyce and Reich 2015). Although we cannot 
stop the march of time, the manner in which one ages can vary greatly; thus there is significant 
research interest in understanding the biological basis of healthy ageing (Li and Schmiedek 2002).  
 
Gastrointestinal (GI) disorders are frequently reported in elderly individuals, with 35-40% of 
patients reporting at least one GI complaint (Tran and Greenwood-Van Meerveld 2013). These 
include malnutrition as a result of poor nutrient absorption, reduced gut motility, associated with 
constipation, diverticulosis from structural weakening of the GI tract, and increased susceptibility to 
colon cancer (Langille et al. 2014). Ageing in humans and laboratory animals is also related to 
increased intestinal permeability and increased colonic cytokine expression resulting in chronic 
systemic inflammation which has been termed “inflammaging,” (Tran and Greenwood-Van 
Meerveld 2013, Deleidi et al. 2015, Peterson et al. 2015).  
  
The mechanisms underlying the increased intestinal permeability and peripheral inflammation are 
still unclear, but the gut microbiota is thought to play a critical role. It is now widely recognised that 
the gut microbiota is a key modulator of homeostasis, and perturbation of its composition can 
result in gut dysfunction. Furthermore, the composition of the gut microbiota in both humans and 
laboratory animals varies across the lifespan (Rehman 2012, Biagi et al. 2013, Jeffery and 
O'Toole 2013, Langille et al. 2014, Lynch et al. 2015). In general, as an individual ages, the 
microbiota shifts in numerous ways that may predispose one to inflammation. 
 
In addition to the physical deterioration of the body, such as increased risk of disease and frailty, 
there is great interest in the effects of ageing on the central nervous system (Lee et al. 2000, 
Prenderville et al. 2015). Psychiatric conditions, most notably anxiety, depression, and social 
withdrawal are frequently reported in the elderly (Kastenschmidt and Kennedy 2011, Prenderville 
et al. 2015). It is also well established that peripheral inflammation can directly affect 
neuroimmune processes in the central nervous system (CNS) resulting in impaired cognitive 
function (Block et al. 2007, Perry 2010, Zheng et al. 2015). Moreover, circulating inflammatory 
markers are often elevated in individuals with mood disorders (Block et al. 2007, Perry 2010, 
Young et al. 2014, Zheng et al. 2015, Kelly et al. 2016). It is therefore likely that age-related 
alterations in intestinal microbiota and function contribute to chronic systemic inflammation. This 
may, in turn, lead to central inflammation, manifesting in cognitive impairment.   
 
Taken together, it is clear that the microbiota-gut-brain axis plays a critical role in health, and 
perturbations in this axis have been implicated in numerous pathological conditions. However, 
there are a limited number of studies focused on its impact on ageing-induced behavioural and 
neurobiological outcomes, notwithstanding Metchnikoff’s theory that microbes may be the 
underpinnings of longevity (Cryan and Dinan 2015). To this end, we hypothesised that alterations 
in the gut microbiota of young and aged mice will correlate with changes in intestinal permeability, 
inflammation and neurobehavioural outcomes.  
  
2. Methods 
 
2.1. Animals 
All animal protocols were approved by the Animal Experimentation Ethics Committee at University 
College Cork (UCC) and by the Health Products Regulatory Authority (HPRA) of Ireland, in 
accordance with EU Directive 2010/63/EU. Twelve young (2 month old) and 10 aged (18 month 
old) male C57BL/6J mice were obtained from Charles River (France) and housed 2-4 per cage. All 
mice were housed in the same temperature and humidity-controlled animal room with a 12 h 
light:dark cycle and were maintained on ad libitum standard chow and water unless otherwise 
noted. Mice were given 4 weeks to recover from transportation and acclimate to the UCC animal 
facility. 
 
2.2 Behavioural testing 
All mice were exposed to a battery of well-validated behavioural tests designed to assess 
cognitive function as well as depressive- and anxiety-like behaviours over a period of 5 weeks. 
Young mice were approximately 2-3 months old and aged mice were approximately 20-21 months 
old at the time of behavioural testing. Behavioural tests were performed in what we considered to 
be increasing severity to lessen the likelihood of the prior testing influencing future tests. Tests 
were performed in the following order: 1) Object location, 2) Y-maze, 3) 3 chamber, 4) elevated 
plus maze, 5) open field, 6) forced swim and 7) gut permeability tests.  A washout period of 2 days 
was observed between behavioural tests 1-6. A washout period of 2 weeks followed the FST, and 
4 weeks followed gut permeability testing and prior to cull. 
 
2.2.1 Spontaneous alternation in the Y-maze 
The Y-maze was performed as a test of spontaneous alternation, used to assess exploration, 
cognition and hippocampal-dependent memory (Hughes 2004, Senechal et al. 2007). It is based 
on the premise that mice will alternate between arms visited when exploring a new environment. 
The test was performed as previously described with minor adaptation (Senechal et al. 2007). 
  
Mice were brought into the testing room and allowed to habituate for at least half an hour before 
testing. The Y-maze was constructed from black plastic and each arm measured 16 x 6.5. Lighting 
within the Y-maze was 25 lux. The mouse was placed at the end of the first arm facing the wall. 
Behaviour was videorecorded from above for 5 min after placement within the maze. The Y-maze 
was wiped down with 70% ethanol between tests. An entry into an arm was noted when all 4 paws 
crossed into the area. Alternation was noted as the number of consecutive entries into the three 
maze arms. This was calculated as the number of alternations divided by the total number of arm 
entries during the 5 min test period.  
 
2.2.2 Novel Object/Object Displacement test 
The combined Novel Object/Object Displacement test (NOR) was used to assess cognitive 
function, including and spatial working memory and is based on the premise that mice will spend 
more time interacting with a novel or displaced object in comparison with a familiar object in a 
familiar location (Antunes and Biala 2012). Mice were brought into the testing room and allowed to 
habituate for at least half an hour before testing. The test arena was a grey plastic box, measuring 
32 x 40 cm.  Lighting within the test arena was approximately 60 lux. The arena was wiped with 
ethanol after each test. Day one consisted of habituation to the empty test arena; the mouse was 
placed in the centre and allowed to explore for 10 min, while behaviour was videorecorded from 
above. After this period, the mouse was returned to its home cage. The acquisition phase of the 
study was performed on day 2. Again, mice were given at least 30 min to habituate to the testing 
room. During the acquisition phase, the mouse was placed in the centre of the test arena where 2 
identical objects were placed. The mouse was allowed to explore for 10 min, after which it was 
returned to its home cage. After a 3 h period, the mouse was returned to the test arena with the 
same objects, however one of the objects was now in a different location. The mouse was allowed 
5 min to explore and time spent interacting with the 2 objects was videorecorded, after which it 
was returned to its home cage. This comprised the Object Displacement phase of the study. 
Following a 5 min break, the mouse was returned to the test arena where the displaced “familiar” 
object was replaced with a novel one. Behaviour was videorecorded from above for 5 min, and 
  
afterwards the mouse was returned to its home cage. However, due to technical issues no 
useable data was obtained for this Novel Object phase of the study. Because the novel object 
phase followed the object displacement phase, object displacement results were unaffected. 
Exploration of an object was defined as orientation of the mouse with its nose 2 cm or closer to the 
object. 
 
2.2.3 Open field test 
The open field (OF) test was used to assess locomotor activity and anxiety-like behaviour and is 
based on the premise that mice will avoid open areas (the centre of the test arena), which are 
anxiety-provoking and will spend more time near the walls (thigmotaxis) (Hall and Ballachey 1932, 
Gould 2009). Mice were brought into the testing room and allowed to habituate for at least half an 
hour before testing. The OF arena was a white plastic box measuring 32 x 40 cm and the test was 
performed under full light conditions (1000 lux). Mice were placed in the centre of the arena and 
behaviour was recorded from above for 10 min. Mice were returned to their home cage following 
the test and the arena was wiped down with ethanol. Distance travelled and entries into centre of 
the arena was analysed using Ethovision (Noldus, Waeginingen, Netherlands).  
 
2.2.4 Elevated Plus Maze 
The elevated plus maze (EPM) was used to assess anxiety-like behaviour and is based on the 
premise that mice prefer enclosed areas when exposed to a novel environment and will spend 
less time in open areas, which are anxiety-inducing (Pellow et al. 1985). Mice were brought into 
the testing room and allowed to habituate for at least half an hour before testing. The room was lit 
by one red light and the lighting in the centre of the EPM measured 9 lux.  The elevated plus maze 
was constructed of black plastic and had 4 arms measuring 50 x 5 cm.  Walls on the 2 closed 
arms were 15 cm high whereas the 2 open arms had no walls. The plus maze rested on a platform 
1 m high. For testing, the mouse was placed in the centre of the EPM facing an open arm. 
Behaviour was videorecorded from above for 5 min, after which the mouse was returned to its 
home cage. The EPM was wiped down with ethanol solution between each test. Entry into each 
  
arm was noted when all 4 paws crossed into the arm. The number of entries and percentage of 
time spent in open and closed arms were calculated. 
 
2.2.5 Forced swim test 
The forced swim test (FST) was used to assess antidepressant-sensitive behaviours and is based 
on the premise that immobility, performing the minimum amount of movement to keep one’s head 
above water, is a marker of depressive-like or despair-like behaviour (Porsolt et al. 1978, Porsolt 
1979, Cryan and Mombereau 2004). FST was performed under full light conditions (1000 lux). The 
tank was a glass cylinder measuring 21 cm in diameter and filled to a depth of 15 cm with 24°C 
tap water. The test was videorecorded from above for 6 min, and afterwards the mouse was 
removed from the tank, dried with a towel and placed into an individual cage for recovery. Ninety 
minutes post-test, mice were returned to their home cages. Water was changed between each 
test. Immobility was assessed for the last 4 min of the FST and was defined as the animal not 
actively swimming or moving and performing the minimal amount of activity necessary to keep the 
head above water.   
 
2.2.6 3-chamber test of social behaviour 
Sociability was assessed using the 3-chamber social interaction test (SIT), in which time spent 
interacting with a novel conspecific is compared to time spent with a novel object or familiar 
conspecific. It is based on the premise that mice will spend more time interacting with a novel 
conspecific than novel object, and that they will prefer a novel conspecific to a familiar one. Mice 
were brought into the testing room and allowed to habituate for at least half an hour before testing. 
The 3-chamber social interaction test was performed as previously described (O'Tuathaigh et al. 
2007, Desbonnet et al. 2014). The test arena consisted of 3 chambers; the left and right chambers 
measured 13.5 x 20 x 20 cm and the centre chamber was 9 x 20 x 20 cm. A solid partition 
separated the chambers, which could be replaced with partitions with a small hole enabling access 
to the other chambers. There were 3 phases of the test: habituation, sociability, and social novelty 
preference. All phases of the test were 10 min in duration, performed sequentially and 
  
videorecorded from above for later analysis. During phase 1, the habituation phase, the mouse 
was placed into the centre chamber and then allowed access to the empty left and right chambers 
for 10 min. The mouse was then returned to the centre chamber and a novel mouse was placed in 
a mesh cage in one of the side chambers, whereas a novel object (a small rubber duck) was 
placed in a mesh cage in the other side chamber for phase 2. Location of the novel mouse and 
novel objects were randomised between animals to eliminate side preferences. The mouse was 
then allowed to explore these chambers for 10 min, after which it was returned to the centre 
chamber. For the 3rd phase, a new, novel mouse was placed in the mesh cage that had previously 
housed the novel object. The mouse was then allowed to explore the chambers, which held the 
familiar mouse (from phase 2) and the novel mouse, for 10 min. The 3-chamber apparatus was 
cleaned with ethanol between animals. The number of entries and time spent in each chamber 
were then measured.  
 
2.3 Intestinal permeability (FITC-D) 
Intestinal barrier function was assessed using fluorescein isothiocyanate-labelled dextran (FITC-D) 
(FD4, Sigma Aldrich, Ireland). FITC-D (MW= 4 kDa) was dissolved in phosphate buffered saline 
(pH 7.4) to make a solution of 80 mg/ml. Mice were fasted overnight, prior to the study, and in the 
morning (9.00), they were gavaged with FITC-D (600 mg/kg). Two hours following gavage, mice 
were placed in ventilated plastic restrainers and a basal blood sample was taken. Briefly, a scalpel 
blade was used to remove the very tip (<1mm) of the tail. Blood was then collected using a 
heparinised capillary tube and transferred to a microcentrifuge tube. To assess the impact of acute 
stress on gut permeability, a small piece of gauze was used to gently remove the clot at the tip of 
the tail and another blood sample was collected 1 h post-restraint. Mice were then returned to their 
home cages. Blood samples were kept on ice and then centrifuged at 2500 x g. Plasma was 
collected and stored at -20°C for later analysis. To assess FITC-D, samples were analysed using 
a spectrometer (Victor Spectrometer, excitation max= 490 nm, emission max= 520 nm). Serial 
dilutions of FITC-D in PBS were used to generate a standard curve. A separate aliquot of plasma 
  
was collected at each time point to assess basal and stressed corticosterone levels (as described 
in section 2.4). 
 
2.4 Corticosterone response to acute stress 
Plasma corticosterone (CORT) levels prior to, and following exposure to forced swim and restraint 
stress were used to assess hypothalamic-pituitary-adrenal (HPA) axis activity. On the day of the 
forced swim test, each mouse was removed from its home cage and moved to a testing room 
where a basal blood sample was taken (as described in section 2.3). Blood samples were also 
taken 15, 45, and 90 min following the onset of the FST to assess peak and recovery CORT 
levels. Blood was processed as previously described, and stored at -20°C for later analysis. Blood 
samples were also collected to assess HPA axis response to restraint stress (in conjunction with 
the FITC-D test of intestinal permeability, described in 2.3). Plasma CORT was assessed by 
ELISA, following vendor instructions (ENZO Corticosterone ELISA, ADI-900-097, Enzo Life 
Sciences, Exeter, UK).    
 
2.5 Plasma cytokines 
At the end of the study, trunk blood was collected and processed as described above for collection 
of plasma. Samples were analysed using the MSD V-Plex Custom Mouse Cytokine kit 
(MesoScaleDiscovery, Brinny, Ireland) as per vendor instructions. The lower limits of detection for 
the kit ranged from 0.11 pg/ml (IL-1β) to 0.95 pg/ml (IL-10). 
 
2.6 Caecal microbiota analysis 
2.6.1 DNA extraction 
Caecal contents were snap frozen at the end of the study and stored at -80°C until the samples 
could be processed. DNA was extracted from caecum using the QIAmp Fast DNA Stool Mini Kit 
(Qiagen, UK) according to manufacturer’s instructions with the addition of a 3 min vortex step 
using 2 ml screw-cap tubes (Sarstedt, Wexford, Ireland) containing 0.25 g of a 1:1 mix of 0.1 mm 
and 1.5 mm diameter sterile zirconia beads plus a single 2.5mm diameter bead (BioSpec 
  
Products, Bartlesville, USA). Briefly, 200 mg of each caecal sample was added to a screw-cap 
tube containing beads with 1 ml of Qiagen InhibitEX® Buffer and vortexed for 3 min. Samples 
were then incubated at 70°C for 5 min to lyse cells. Samples were centrifuged and the DNA was 
pelleted and treated with proteinase K. The DNA was then washed with buffers AW1 and AW2 
and eluted in 200 µl Buffer ATE. DNA was quantified using the Qubit™ 3.0 Fluorometer (Bio-
Sciences, Dublin, Ireland) along with the high sensitivity DNA quantification assay kit (Bio-
Sciences, Dublin, Ireland). 
 
2.6.2 PCR and 16S compositional sequencing 
The V3-V4 regions of the 16S rRNA gene were amplified and prepared for sequencing according 
to the 16S Metagenomic Sequencing Library Protocol 
http://www.illumina.com/content/dam/illumina-
support/documents/documentation/chemistry_documentation/16s/16s-metagenomic-library-prep-
guide-15044223-b.pdf. The protocol involved two PCR reactions on the extracted DNA. The DNA 
was first amplified using primers specific to the V3-V4 regions of the 16S rRNA gene: (Forward 
primer 5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG; reverse 
primer 5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC). 
Each reaction contained 2.5 µl genomic DNA, 5 µl forward primer (1 µM), 5 µl reverse primer (1 
µM) and 12.5 µl 2X Kapa HiFi Hotstart ReadyMix (Kapa Biosystems Ltd., UK). PCR amplification 
was carried out using the following program: 95°C x 3 min, 25 cycles of 95°C x 30s, 55°C x 30s, 
72°C x 30s, 72°C x 5 min and held at 4°C. PCR products were visualised using gel 
electrophoresis and then purified using AMPure XP beads (Labplan, Kildare, Ireland). Following 
this, a second PCR reaction was carried out on the purified DNA using two indexing primers per 
sample (Illumina Nextera XT indexing primers, Illumina, Netherlands). Each reaction contained 5 
µl purified DNA, 5 µl index 1 primer (N7xx), 5 µl index 2 primer (S5xx), 25 µl 2x Kapa HiFi Hot 
Start Ready mix and 10 µl PCR grade water. PCR amplification was completed using the previous 
program but with only 8 amplification cycles instead of 25. PCR products were visualised and 
purified as described above. Samples were quantified using the Qubit™ 3.0 Fluorometer (Bio-
  
Sciences, Dublin, Ireland) along with the high sensitivity DNA quantification assay kit and then 
pooled in an equimolar fashion (20 nM). The sample pool was prepared following Illumina 
guidelines and sequenced on the MiSeq sequencing platform in Clinical Microbiomics, Denmark 
using standard Illumina sequencing protocols. 
 
2.6.3 Bioinformatic Analysis 
Paired-end reads were assembled using FLASH. Raw sequence reads were quality trimmed using 
the QIIME suite of tools (version 1.8.0). This included the filtering of reads which failed to reach a 
quality score of > 25 and the removal of mismatched barcodes and sequences below length 
thresholds. Denoising, chimera detection and operational taxonomic unit (OTU) grouping at 97% 
similarity were performed in QIIME using USEARCH v7. OTU sequences were aligned using 
PyNAST and the SILVA SSURef database release 111 was used to determine taxonomy. The 
vegan R package (v. 2.4-1) was used to for statistical calculations of alpha and beta diversity. 
Alpha diversity was calculated using the Shannon Index, Mann Whitney U test was performed to 
assess significance between groups. Principal coordinate analysis (PCoA) plots were used to 
visualise beta diversity between groups based on Bray-Curtis distance matrices; significance of 
beta diversity between groups was computed by performing an ADONIS PERMANOVA test.  
 
2.7 Statistical Analyses 
All data, with the exception of microbiota data, are presented as mean +/- SEM. Data were 
excluded from analyses if greater than 2 standard deviations from the mean. Two-way ANOVAs 
were used to assess percentage of time interacting for Object location, social interaction, plasma 
FITC-D and CORT. When a main effect was detected, a Bonferroni post-hoc test of multiple 
comparisons was used. Unpaired t-tests were used to analyse behaviour in the OF, EPM, FST 
and plasma cytokines. Correlations were performed using Spearman correlation coefficient (r). 
Mann Whitney U analysis was used to assess statistical differences in microbiota compositions 
and p-values were corrected for multiple comparisons using the Benjamini Hochberg (BH) 
correction (FDR<0.05). Microbiota were analysed by subject rather than cage.  
  
3. Results 
 
3.1 Aged mice do not differ in spontaneous alternation behaviour, but exhibit impaired displaced 
object recognition. 
Ageing is associated with cognitive decline, including impaired memory. Therefore, we performed 
the Y-maze test of spontaneous alternation and a novel object/object location test to assess 
memory in aged and young mice. Aged mice performed similarly to young mice in the 
spontaneous alternation test (Fig. 1A). Whereas young mice spent a significantly greater 
percentage of time interacting with a displaced familiar object (p<0.01), aged males did not (Fig. 
1B).  
 
3.2 Aged mice exhibit behaviours associated with anxiety but not depression.   
Because ageing is often associated with changes in mood, we also investigated anxiety- and 
depressive- like behaviours using the open field, elevated plus maze, and forced swim tests. Aged 
mice spent less time in the centre arena and made fewer entries into this area during the open 
field test (p<0.01) (Fig. 1C and 1D). Aged animals also spent a significantly lower percentage of 
time in the open arms of the plus maze (p<0.05) (Fig 1E), and together, these findings suggest 
increased anxiety. Immobility, used as a marker of depressive- or despair- like behaviour did not 
differ between young and aged mice in response to the forced swim test (Fig. 1F).  
 
3.3 Aged mice exhibit behaviours associated with reduced social recognition and/or preference for 
social novelty.   
As ageing is also associated with social withdrawal, social preference and social recognition were 
assessed using the 3-chamber social interaction test. Both aged and young mice spent more time 
investigating a novel mouse as opposed to a novel object, suggesting that there were no 
differences in preference for a conspecific (p<0.0001)(Fig. 2A). However, whereas younger mice 
spent significantly more time interacting with a novel mouse than a familiar mouse (p<0.0001), 
  
aged mice spent similar amount of time investigating the novel and familiar mice, suggesting an 
impairment in social recognition or a reduced preference for social novelty (Fig. 2B).  
 
3.4 Aged mice exhibit increased basal gut permeability, which is further exacerbated by acute 
stress exposure.   
Gut permeability was assessed in young and aged mice prior to and following 1 h of restraint 
stress. Aged mice had significantly greater basal intestinal permeability than young mice (p<0.05). 
Whereas gut permeability of young mice was unaffected by restraint stress, permeability was 
further enhanced in aged mice (Aged basal v. aged stressed, p<0.01, Young stressed v. aged 
stressed, p<0.001) (Fig. 3).  
 
3.5 Aged mice exhibit alterations in corticosterone response to acute stress exposure. 
Despite seeing no behavioural effect, aged mice exhibited altered plasma CORT responses to the 
FST. Although basal CORT levels did not differ between groups, aged mice had significantly lower 
plasma CORT levels 15 min following the onset of the test (p<0.001) (Fig. 4A). Plasma CORT did 
not differ 45 and 90 min post FST; however, the trajectory of the CORT response differed. 
Although levels were dropping at these time points in young mice, suggesting recovery, they were 
rising in aged mice, suggesting prolonged CORT release. CORT was also measured pre- and 
post- acute restraint, which was employed during the FITC-D test of intestinal permeability. Similar 
to our findings in the FST, basal CORT levels did not differ between young and aged mice. 
However, while plasma CORT was significantly increased in young mice following 1 h of restraint 
(p<0.001), CORT was unchanged in aged mice (young-stressed v. aged-stressed, p<0.001) (Fig. 
4B). 
 
3.6 Circulating plasma cytokines are elevated in aged mice and correlate with gut FITC-D 
permeability 
Plasma cytokines were assessed as markers of peripheral inflammation at the end of the study. A 
number of pro-inflammatory cytokines were elevated in aged mice, including IL-1β (Fig. 5A, 
  
p<0.01), TNF-α (Fig. 5B, p<0.0001) and IL-2 (Fig. 5C, p<0.01). There was a trend towards 
increased IL-6 expression in aged mice (Fig. 5E, p=0.07). Anti-inflammatory cytokine IL-10 was 
unchanged in aged mice (Fig. 5F). Plasma cytokines assessed at the end of the experiment were 
also plotted against plasma FITC-D levels assessed prior to and following restraint stress. In the 
basal state, IL-6 and TNF-α were significantly and positively correlated with plasma FITC-D levels 
(p<0.05), while there was a trend towards positive correlation between IL-1β (p=0.07), (Fig. 6A). In 
the stressed state, all 3 of these cytokines were significantly and positively correlated with plasma 
FITC-D levels (p<0.05) (Fig. 6B).   
 
3.7 The caecal microbiota of mice is significantly altered with ageing 
MiSeq sequencing yielded a total of 8,339,660 raw reads, ranging from 108,541 to 339,456 reads 
per sample. Following quality filtering, reads were clustered into 1033 OTUs, which were assigned 
to taxa from phylum to genus level. Due to the variation in read number, the OTU table was 
rarefied to 108,000 reads, to allow for comparison between samples. The microbiota of aged mice 
differed significantly from that of young mice. Interestingly, only significant increases in bacterial 
taxa were seen in aged mice compared to young (Table 1).  
 
At phylum level the most prevalent microbial taxa in both sample groups were Bacteroidetes and 
Firmicutes accounting for a combined relative abundance of >95% in the young and aged samples  
(Fig. 7). Other bacterial phyla had relative abundances of <2% in both groups. The large 
abundance of S24-7 and Rikenellaceae at family level was reflected at genus level as S24-7 
uncultured, Alistipes, and RC9 gut group. Together, these highly abundant genera account for 
approximately 50% relative abundance at the genus level in both aged and young mice.  
 
Several statistically significant changes in bacterial groups were observed in aged mice (Table 1). 
At the phylum level, TM7 was significantly higher in aged mice (p<0.01). At family level abundance 
less than 1%, significant increases in Porphyromondaceae (p<0.01), TM7 uncultured (p<0.01) 
Clostridiaceae (p<0.05), Thermoanaerobacteraceae (p<0.05), Desulfovibrionaceae (p<0.05) and 
  
Oxalobacteraceae (p<0.05) were seen in aged mice compared to young. Genera Odoribacter was 
much higher in the aged group (5.14%) than in the young mice (0.16%) (p<0.01). In addition, aged 
mice had significant increases in other bacterial genera, including Butyricimonas (p<0.01), TM7 
uncultured (p<0.01), Gelria (p<0.05), Anaerosporobacter (p<0.05), Clostridium (p<0.05), 
Oxalobacter (p<0.05). 
 
The Chao 1 index (which estimates species richness) was significantly higher in the aged group 
(p=0.01). In addition, the number of observed species and the phylogenetic diversity were also 
higher in the aged mice (p=0.01, p=0.03). The Shannon Index (alpha diversity) was significantly 
higher in aged mice (p<0.0001, Fig. 8A). Beta diversity was significantly different between aged 
and young groups (p=0.001, Fig. 8B).  
 
3.8 The relative abundance of Porphyromonadaceae correlates with anxiety-like behaviour in aged 
mice 
Because some of the microbiota changes observed have been associated with cognitive 
dysfunction, we compared relative abundance of 3 taxa that were significantly altered in aged 
mice, Porphyromonadaceae, Odoribacter and TM7, with behavioural data. Interestingly, in aged 
mice, the relative abundance of members of the family Porphyromonadaceae was significantly and 
negatively correlated with the number of entries and time spent in the open arms of the elevated 
plus maze (Fig. 9A and 9B, p<0.05). That is, as Porphyromonadaceae increased in caecal 
contents, so did anxiety-like behaviour in aged mice. No correlations with anxiety-like behaviours 
were found in young mice, as presence of taxa from the Porphyromonadaceae family was so low. 
We found no other correlations between behaviours and the relative abundance of 
Porphyromonadaceae, Odoribacter or TM7 bacterial groups.   
  
Discussion 
 
Although the microbiome has been implicated in the ageing process, there have been few studies 
investigating the age-related changes in microbiota concomitant with gut permeability, stress 
response, peripheral inflammation and behaviour. Here we show that ageing is associated with 
marked changes in microbiota composition coupled with behavioural and physiological alterations. 
 
Some of the most troubling features associated with ageing are negative affect and cognitive 
decline (Eshkoor et al. 2015, Prenderville et al. 2015). In these studies, we found that aged mice 
exhibited several behavioural changes that are thought to reflect these symptoms. The most 
robust of these were increases in anxiety-like behaviours, as assessed by thigmotaxis during the 
open field test and less time spent in the open arms of the elevated plus maze. It should be noted 
that aged mice exhibit reductions in overall locomotor activity; therefore, all data were expressed 
as percentages to avoid this as a confounding variable. However, we cannot rule out the 
possibility that reduced activity influenced the results. Anxiety is often reported in the elderly, as 
are anxiety-like behaviours in aged laboratory animals (Kastenschmidt and Kennedy 2011, 
Brouwer-Brolsma et al. 2014, Andreescu and Varon 2015, Ellison et al. 2015, Creighton et al. 
2016). Importantly, epidemiological studies suggest that anxiety disorders in the elderly 
predispose or exacerbate the onset of cognitive impairments and other conditions, including 
cardiovascular disease (Andreescu and Varon 2015). 
 
Impaired performance of aged mice in the object displacement task is in line with other studies 
suggesting age-associated deficits in hippocampal-dependent spatial memory (Klencklen et al. 
2012, Maasberg et al. 2012, Wimmer et al. 2012). Whereas both young and aged mice 
demonstrated a preference for a novel conspecific over a novel object, aged mice did not exhibit a 
preference for novel mice when presented with the choice between novel and familiar mice. 
However, it is unclear whether these findings reflect a true impairment in social recognition or a 
lack of preference for a novel conspecific.  
  
In addition to alterations in behaviour, aged mice exhibited several physiological changes. It is well 
established that many aspects of gut function, including intestinal barrier function, are impaired 
with age, and we observed a similar impairment in aged mice (Tran and Greenwood-Van 
Meerveld 2013, Man et al. 2014, Saffrey 2014). Interestingly, acute restraint stress exacerbated 
gut permeability in aged animals, despite a lack of rise in plasma glucocorticoid levels; in our 
studies, aged mice actually had a blunted and slower HPA axis response to acute stress, although 
it appears that they may also experience prolonged corticosterone release. The reason for this 
disconnect between plasma glucocorticoids and increased gut permeability is unclear, as the 
general consensus is that elevations in glucocorticoids contribute to increased gut permeability 
(Meddings and Swain 2000, Bhatia and Tandon 2005). However, other studies suggest that 
glucocorticoids may actually serve to protect the gastrointestinal tract (Filaretova 2007). 
Furthermore, Crohn’s disease, marked by increased inflammation and gut permeability has been 
associated with hypoactivity of the HPA axis; this may arise because glucocorticoids have anti-
inflammatory effects, and insufficient corticosteroid levels may result in excessive inflammation 
(Stasi and Orlandelli 2008). Although ageing is often associated with basal hyperactivity of the 
hypothalamic-pituitary-adrenal axis, blunted and delayed activation and recovery of the HPA axis 
has also been previously reported (Veldhuis et al. 2013, Buechel et al. 2014). Furthermore, it has 
been previously demonstrated that the intestinal microbiota is sensitive to stress exposure, and 
this may in turn, modulate immune responses (Bailey 2014, Mackos et al. 2016). In the current 
study we employed acute stressors, but future studies will incorporate chronic stress, which is 
particularly relevant to unhealthy ageing. 
 
Numerous factors are thought to contribute to age-associated impairments in gut function. These 
include histological changes within the structure of the gut, including decreased expression of tight 
junction proteins and altered morphology of intestinal villi (Tran and Greenwood-Van Meerveld 
2013, Ren et al. 2014). Mucous and bicarbonate secretion by the gut and short chain fatty acid 
(SCFA) production by the gut microbiota, which serve to protect the intestinal epithelia, also 
decrease with ageing (Woodmansey 2007, Rehman 2012, Saffrey 2014). Moreover, gut motility is 
  
also often reported to decrease in the elderly and in aged laboratory animals, likely due to 
changes in the smooth muscle structure, gut innervation and disrupted signalling.  
Previous studies have demonstrated that the gut microbiota also influences gut permeability and 
behaviour (Saffrey 2014, Yarandi et al. 2016). The age-related changes in microbiota that we 
observed have been previously implicated in inflammation and cognitive decline. The most 
significant increases that we observed are seen in phylum TM7, family Porphyromonadaceae and 
genus Odoribacter. These bacteria have been previously associated with inflammatory diseases 
such as cirrhosis and inflammatory bowel disease (IBD) (Collins et al. 2012, Giannelli et al. 2014). 
Interestingly, our studies also revealed changes in bacteria previously associated with cognitive 
decline. In a study of encephalopathic patients with cirrhosis, increases in Porphyromonadaceae 
positively correlated with increased cognitive dysfunction (Bajaj et al. 2012, Collins et al. 2012). A 
more recent study found that poor cognitive performance in the elderly was associated with 
increases in Porphyromonadaceae irrespective of cirrhosis (Bajaj et al. 2016). Caecal microbiota 
analysis in our studies revealed bacterial changes that have been previously observed in studies 
of depression and exposure to psychological stressors (Bangsgaard Bendtsen et al. 2012, 
Desbonnet et al. 2015, Watanabe et al. 2016). We found that relative abundance of 
Porphyromonadacea was directly correlated with anxiety-like behaviours in aged mice. Increases 
in bacterial taxa from this family have also been observed in faecal samples from individuals with 
Major Depressive Disorder (Jiang et al. 2015). While we did not observe behavioural changes in 
the forced swim test, a common assay of antidepressant-sensitive behaviours, this may reflect the 
overall sensitivity of the test. In future studies we may incorporate other methods of assessing 
depressive-like behaviour across different endophenotypes of the disorder (Slattery and Cryan 
2012, Slattery and Cryan 2014, Kelly et al. 2016). The increased anxiety that we observed in aged 
mice may reflect microbiota changes in stress sensitivity, as noted above (Bangsgaard Bendtsen 
et al. 2012, Desbonnet et al. 2014, Watanabe et al. 2016). Interestingly, the caecal microbiota of 
aged mice was significantly more rich and diverse than that of young mice. Reductions in microbial 
diversity are often reported with ageing, but recent studies have challenged these findings (Biagi 
et al. 2012). The reasons for increased diversity in aged mice is unclear; however, decreases in 
  
diversity are often reflective of unhealthy ageing and frailty, which we did not subjectively observe 
in this study (Claesson et al. 2012, Jackson et al. 2016). Another possibility is that with ageing, the 
stability of the microbiota is reduced, leading to proliferation of opportunistic bacteria (Biagi et al. 
2012).  
 
Perturbations in gut structure, function, and microbiota are believed to contribute to an increased 
risk of infection and inflammation, and markers of inflammation and immune responses have been 
reported in aged humans and in laboratory animals (Krabbe et al. 2004, Chung et al. 2009, Tran 
and Greenwood-Van Meerveld 2013, Man et al. 2014, Mabbott 2015). Similarly, we observed that 
plasma levels of several pro-inflammatory cytokines were elevated in aged mice, and IL-6, IL-1β 
and TNF-α correlated positively with gut permeability. Indeed, chronic systemic inflammation is 
linked to numerous neurodegenerative disorders and cognitive deficits associated with ageing, 
including Alzheimer’s disease (Chung et al. 2009, Perry 2010, Deleidi et al. 2015). Moreover, there 
is a growing literature linking microbiome-based changes with susceptibility to Alzheimer’s disease 
and neurodegenerative disorders (Cattaneo et al. 2016, Frohlich et al. 2016, Xu and Wang 2016).  
 
In conclusion, we show, for the first time to our knowledge, that perturbations of the microbiome-
gut-brain axis, resultant of normal ageing, may contribute to peripheral inflammation and the 
development of altered anxiety behaviours and cognitive impairments. Aged male mice exhibited 
significant shifts in gut microbiota and marked differences in stress responsivity, gut permeability 
and peripheral inflammation in comparison with young adult mice. In addition, they exhibited 
behavioural changes associated with cognitive deficits and increased anxiety. These increases in 
anxiety-like behaviour were directly correlated with abundance of bacteria from the 
Porphyromonadaceae family; this is in agreement with recent studies finding an association 
between this family and cognitive dysfunction and mood disorders (Collins et al. 2012, Jiang et al. 
2015, Bajaj et al. 2016). Future studies should focus on the mechanisms that are at play in driving 
these changes. There is increasing emphasis on understanding pathways of microbiome to brain 
signalling (including vagus nerve, neuroendocrine pathways, enteric nervous system short chain 
  
fatty acids, tryptophan metabolism and the immune system) but there is still a lack of knowledge in 
this field (Cryan and Dinan 2012, Galland 2014, O'Mahony et al. 2015, Rogers et al. 2016). 
Moreover, the microbiome has been shown to regulate adult hippocampal neurogenesis 
(Ogbonnaya et al. 2015, Mohle et al. 2016), microglia activation (Erny et al. 2015), blood brain 
barrier function (Braniste et al. 2014) and neuroinflammation (D'Mello et al. 2015), all of which are 
altered in ageing. Future studies should also address the relative contribution of these to the 
alterations in behaviour seen in ageing. These studies suggest that the gut microbiota may prove 
a worthy target for the development of novel therapies to ameliorate or prevent some of the 
adverse neurobehavioural consequences of unhealthy ageing.  
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FIGURE LEGENDS 
 
Figure 1. Behavioural tests of cognitive function, anxiety-, and depressive-like behaviours in 
young (n=9-12) and aged (n=8-10) mice. (A) No differences in spontaneous alternation were 
observed. (B) Young mice spent a significantly greater percentage of time interacting with a 
displaced, familiar object compared to a stationary, familiar object. (C) Aged mice spent 
significantly lower percentage of time in the centre of the open field. (D) Aged mice made fewer 
entries in to the centre of the open field. E. Aged mice spent a significantly lesser percentage of 
time in the open arms of the EPM. F No differences in time spent immobile in the FST. 
*p<0.05,**p<0.01, ***p<0.001 
 
Figure 2. Behaviours of young (n=9) and aged (n=9) mice in the 3-chamber test. (A) Aged and 
young mice spent significantly more time investigating a novel mouse than a novel object. (B) 
Young mice spent significantly more time investigating a novel mouse than a familiar mouse.  
Aged mice exhibited no preference for the novel mouse. 
****p<0.0001 
 
Figure 3. Basal and stress-induced gut permeability in young (n=12) and aged (n=10) mice. Basal 
gut permeability of aged mice was significantly greater than that of young mice and was 
significantly increased in response to acute restraint. Gut permeability of young mice was not 
increased in response to acute restraint stress.   
*p<0.05 **p<0.01 ***p<0.001 
 
Figure 4. Corticosterone response to acute stress exposure in young (n= 12) and aged (n=10) 
mice. (A) Young mice had a significantly greater peak CORT response 15 min after the onset of 
FST (B) Young mice had significantly higher plasma CORT following 1 h of restraint in comparison 
with basal levels and significantly higher plasma CORT than aged mice exposed to restraint.  
***p<0.001 
  
Figure 5. Plasma cytokines in young  (n= 11-12) and aged (n=7-8) mice. (A) Plasma IL-1β was 
significantly elevated in aged mice. (B) Plasma TNF-α was significantly elevated in aged mice. (C) 
Plasma IL-2 was significantly elevated in aged mice. (D) There was no difference in plasma IL-4. 
(E) There was a trend towards increased plasma IL-6 levels in aged mice (p=0.07). (F) Plasma IL-
10 did not differ between young and aged mice. 
**p<0.01 ***p<0.001 
 
Figure 6. Correlation between plasma cytokines and gut permeability in young (n= 11-12) and 
aged (n= 8) mice. A positive correlation was found between plasma cytokines and basal 
(unstressed) gut permeability (A-C) and in response to acute restraint stress (D-F). Open circles 
represent young and shaded circles represent aged mice. 
*p< 0.05  
 
Figure 7. Visual representation of relative abundance of caecal bacterial changes on the order of 
(A) Phylum, (B) Family and (C) Genus of young (n=10) and aged (n=7) mice. Significant changes 
are denoted by bold type. 
 
Figure 8. Alpha diversity, quantified by the Shannon index (A) and beta diversity, represented by 
principle coordinate analysis (B) of caecal bacteria of young (n=10) and aged (n=7) mice. 
 
Figure 9. Correlation between behaviours and relative abundance of Porphyromonadaceae. 
Porphyromonadaceae and (A) time spent in the EPM and (B) entries into open arms of the EPM 
were negatively correlated for aged (n=6) mice.  
*p<0.05 
 
Table 1. Differences in caecal microbiota between young (n=10) and aged (n=7) mice. Arrows in 
bold type denote significant changes within aged mice.  
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Highlights 
 
• The behaviour and physiology of young and aged mice were compared, with an emphasis 
on gut microbiota, gut permeability and markers of peripheral inflammation. 
• Aged male mice exhibited impaired cognitive function and increased anxiety-like behaviour 
in comparison with young adult mice. 
• Gut permeability was increased in aged mice and was exacerbated by acute stress 
exposure. 
• Gut permeability was positively correlated with increases in plasma proinflammatory 
cytokines IL-6, IL-1β and TNF-α. 
• Gut microbiota was altered in aged mice, with increases in phylum TM7, family 
Porphyromonadaceae and genus Odoribacter, which have been implicated in inflammatory 
disorders and cognitive impairments. 
• Relative abundance of Porphyromonadaceae was significantly correlated with anxiety-like 
behaviour of aged mice. 
  
  
 
